Clinical Trial Update: Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on adding hypofractionated high-dose radiation for oligometastatic disease in non-small cell lung cancer; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: RECRUITING